Valneva SE

€2.50As of Sun 8 Nov 2026, 12:00 UTC
EPA:VLAHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 0.09%
Div yield —
ROE (117.85%)
Biotechnology
Beta (5Y) 1.46
PE TTM —
TSR TTM (38.10%)
Mkt cap €476.0M
ROIC (65.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.09
23.42%
(5.46%)
Hold 5|5|4|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.05
0.06
0.06
0.06
16.73%
15.97%
25.66%
24.44%
Revenue€M
39.65
40.21
39.86
39.53
15.35%
12.94%
7.80%
3.77%
Peers (US$534.5M)
Cap (US$)
PE
902.0M
—
595.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.060
—
—
EBIT/Intx
2.072
0.750
0.686
Own earn%
(103.28)
12.34
11.89
Sh yield%
12.77
67.91
68.31
Owners
Insiders/Inst%
8.15
43.73
Short interest%
2.87
SBC / revenue%
3.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
48